1. Soluble CD163 is a biomarker for accelerated atherosclerosis in systemic lupus erythematosus patients at apparent low risk for cardiovascular disease. (2nd January 2020) Authors: David, C; Divard, G; Abbas, R; Escoubet, B; Chezel, J; Chauveheid, MP; Rouzaud, D; Boutten, A; Papo, T; Dehoux, M; Sacre, K Journal: Scandinavian journal of rheumatology Issue: Volume 49:Number 1(2020) Page Start: 33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗